Lumenis At-A-Glance:
- Formed through the merger of ESC Medical Systems and Coherent Medical Group
- Global leader in medical lasers and light-based technology
- Sales presence in more than 100 countries worldwide, with direct sales in the major markets
- Leader in each of its markets—aesthetic, ophthalmic, surgical
- World’s largest installed base: more than 70,000 systems
- Holds 250 patents
- More than 900 direct employees
- Pioneered the use of lasers since 1966
Our Mission
Lumenis commits substantial resources to research and development. This investment in scientific and technological innovation is significant not only in its size and scope, but also in its focus: Enhancing Life. Advancing Technology.
Core Businesses and Products
Lumenis' business includes a diverse product portfolio comprised of aesthetic, ophthalmic, and surgical, as well as world class customer service support.
Lumenis Fiscal Year 2007
Scope of Applications
From doctors' offices and hospitals to medical spas, Lumenis products provide leading-edge solutions for a wide range of conditions, and include applications for the following markets:
At Lumenis, we constantly push the boundaries of laser aesthetics. In fact, Lumenis holds more patents and has proven the effectiveness of our products in more clinical studies than any other aesthetic technology company in the world. Our products remove hair; eliminate facial blemishes, large vessels and spider veins; treat fine lines and wrinkles. The company pioneered
IPL technology and photorejuvenation, an in-office procedure that reduces redness, age spots and fine lines with no patient downtime. We also introduced
Lumenis One, the world’s only fourth-generation IPL system, featuring Optimal Pulse Technology. In 2005, Lumenis launched the
Aluma Skin Renewal System, for non-invasive and virtually painless treatment of fine lines and wrinkles with predictable outcomes. These innovations demonstrate our continued commitment to provide our customers with revolutionary tools that help reveal the true beauty that dwells within. Lumenis is pleased to offer a continuum of solutions to meet the needs of aesthetic patients worldwide, with products that include:
Lumenis One,
LightSheer,
Aluma,
UltraPulse Encore,
IPL Quantum and
Elora.
First then. First now. Since introducing the first laser
photocoagulator to ophthalmology in 1970, Lumenis has focused on providing ophthalmologists innovative laser therapies to preserve and improve the sight of patients worldwide. Attentive to trends in Ophthalmology for early intervention, therapies developed by Lumenis are safe, selective and minimally invasive. Our laser systems, including the highly regarded
Novus Varia and
Selecta II, treat sight-threatening diseases such as diabetic retinopathy, glaucoma, age-related macular degeneration (AMD), and secondary cataracts. Today, Lumenis offers the most complete line of ophthalmic laser solutions in the industry used from the office, clinic and surgery center to the operating room, for treating conditions in the front of the eye to the back, and designed to improve and preserve sight from infancy to old age.
Driven by a passion to serve its surgical customers and their patients, Lumenis Surgical is leading the way to a healthier tomorrow. By offering the most extensive line of laser systems and delivery devices for use in office or hospital settings, Lumenis laser systems are tailored to meet a variety of clinical needs. The available robotic automation of our CO2 family of lasers provide excellent solutions for a variety of specialties, including ENT and Gynecology. The powerful versatility of the Holmium family of lasers offers a multi-application solution for a variety of specialties including Urology and Gastroenterology. Coupled with the long history of safety, efficacy and clinical data, Lumenis Surgical is able to offer the most comprehensive line of laser and light based systems, delivery devices and accessories to the global community.
CHINA
Fact Sheet